SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001818382-24-000086
Filing Date
2024-06-04
Accepted
2024-06-04 19:03:43
Documents
1
Period of Report
2024-06-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1717542215.html 4  
1 FORM 4 wk-form4_1717542215.xml 4 6139
  Complete submission text file 0001818382-24-000086.txt   7672
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Issuer) CIK: 0001818382 (see all company filings)

IRS No.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 35 WILSHIRE ROAD GREENWICH CT 06831
Business Address
Dougan Brady W (Reporting) CIK: 0001878020 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39532 | Film No.: 241020130